Page 6 - Pharma
Indian pharma cos with bigger US presence face more FDA scrutiny: Analysts
Big entities such as Aurobindo and Dr Reddy's have been currently filing for new product approvals from multiple sites
 "Indian pharma cos with bigger US presence face more FDA scrutiny: Analysts")
Develop entire value chain: Dr Reddy's MD tells pharma companies
US-China trade war is going to give us a window of opportunity to expand our industry, says G V Prasad
 "Develop entire value chain: Dr Reddy's MD tells pharma companies")
GPAT 2020 registration process begins: Know important dates, steps to apply
GPAT is a national-level entrance examination for admission to MPharma programmes
Pharma Q2 Preview: Lack of new US approvals to overshadow domestic revival
Analysts expect a 12% growth in revenues for the sector
 "Pharma Q2 Preview: Lack of new US approvals to overshadow domestic revival")
Pharma Monday blues: USFDA warnings drag down Glenmark, Aurobindo stocks
The Nifty Pharma index fell 3.35 per cent during the day.
 "Pharma Monday blues: USFDA warnings drag down Glenmark, Aurobindo stocks")
Pharma PSUs likely to sign MoU with LMA for sale of surplus land
The PSUs thus are hopeful that the sale process could now be expedited
 "Pharma PSUs likely to sign MoU with LMA for sale of surplus land")
We are growing our biosimilars capacity six-fold: Lupin MD Nilesh D Gupta
We were into APIs in the US and we started finished products, said Nilesh D Gupta
 "We are growing our biosimilars capacity six-fold: Lupin MD Nilesh D Gupta")
Pfizer clears the decks for fresh start, looks to energise bestseller list
With six big brands that never hit the high notes in India, bundled into its venture with Mylan, the pharma major looks to energise its bestseller list
 "Pfizer clears the decks for fresh start, looks to energise bestseller list")
India seeks 'clear roadmap' from China to ramp up export of pharma products
Besides pharmaceuticals, India has been asking China to open up its IT market as well to ensure steady increase of Indian exports
 "India seeks 'clear roadmap' from China to ramp up export of pharma products")
Indian pharma industry likely to grow by 11% to $41.9 bn in FY20: Report
The industry is expected to grow at around 12 per cent and reach $20.4-$20.8 billion in the domestic market
 "Indian pharma industry likely to grow by 11% to $41.9 bn in FY20: Report")
Pharma's share in greenhouse emissions more than automotive sector: Study
More than 200 companies represent the global pharmaceutical market, yet only 25 consistently reported their direct and indirect greenhouse gas emissions in the past five years
 "Pharma's share in greenhouse emissions more than automotive sector: Study")
Private pharmacy chains warming up to unbranded generic medicines
Private chains such as Generico and StayHappi Pharmacy see an opportunity and are aiming to expand rapidly over the coming months
Gujarat sees a surge in small drug firms eyeing regulated export venues
Traditionally, small and medium players had focused on the semi-regulated markets such as Latin America and Africa, among others
 "Gujarat sees a surge in small drug firms eyeing regulated export venues")
Boost in US sales likely to drive re-rating of Indian pharma companies
Price decline has slowed from double digits to lower single digit for Indian pharma companies in US
 "Boost in US sales likely to drive re-rating of Indian pharma companies")
As generic pharma players lag, investors log into Crams companies
Acceleration in outsourcing trend is expected to help Divi's Labs, Jubilant Life and Syngene post strong revenue growth
 "As generic pharma players lag, investors log into Crams companies")
Double-digit spend to catapult domestic pharma growth in the next 5 years
This makes India a country with one of the lowest medicine spends
 "Double-digit spend to catapult domestic pharma growth in the next 5 years")
Pharma margins to get rupee boost in Q2, highlights report
This would also safeguard them from margin pressure, said the report
 "Pharma margins to get rupee boost in Q2, highlights report")
Relax environment norms for export growth, say pharmaceutical firms
Under the current norms, pollution control boards lay down permissible effluent limits while granting approval
 "Relax environment norms for export growth, say pharmaceutical firms")
Pharma majors plan $2-billion investments to tap new business
India's drug makers spent $1.4 billion in the previous financial on R&D
 "Pharma majors plan $2-billion investments to tap new business")
Pharma industry grows 29% to Rs 2.04 lakh cr in 2015-16
The sector saw FDI equity inflows of $2.25 bn from Apr 2014-Mar 2016, says report
 "Pharma industry grows 29% to Rs 2.04 lakh cr in 2015-16")
